网站大量收购独家精品文档,联系QQ:2885784924

干扰素辅助小剂量HA方案治疗慢性粒细胞白血病29例疗效观察.doc

干扰素辅助小剂量HA方案治疗慢性粒细胞白血病29例疗效观察.doc

  1. 1、本文档共6页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
干扰素辅助小剂量HA方案治疗慢性粒细胞白血病29例疗效观察

干扰素辅助小剂量HA方案治疗慢性粒细胞白血病29例疗效观察[摘要] 目的 探讨干扰素辅助小剂量HA方案治疗慢性粒细胞白血病的临床疗效。 方法 选择2002年3月~2011年2月在我院住院的确诊为慢性粒细胞白血病患者58例作为研究对象,随机将其分为观察组和对照组,每组各29例。对照组予以小剂量HA方案,即高三尖杉酯碱(HHT)+阿糖胞苷(Ara-c)。观察组在对照组小剂量HA方案治疗基础上加用重组α-2b干扰素。 结果 观察组血液学缓解总有效率为93.10%,对照组为72.41%,两组比较差异有统计学意义(P < 0.05)。观察组细胞遗传学缓解总缓解率为65.51%,对照组为37.93%,两组比较差异有统计学意义(P < 0.05)。两组患者副作用及副反应发生率比较差异无统计学意义(P > 0.05)。 结论 重组α-2b干扰素联合小剂量HA方案治疗慢性粒细胞白血病具有协同作用,可产生较好的细胞遗传学反应,降低白细胞效果明显,血液学缓解率高,值得临床推广应用。 [关键词] 慢性粒细胞白血病;高三尖杉酯碱;阿糖胞苷;重组α-2b干扰素 [中图分类号] R557+.3 [文献标识码] A [文章编号] 1673-7210(2012)01(c)-0037-02 Clinical observation of interferon combined with low dose HA assisted in the treatment of 29 cases with chronic myelocytic leukemia GUO Ziwen XU Xiaojun Department of Hematology, Zhongshan People’s Hospital, Guangdong Province, Zhongshan 528400, China [Abstract] Objective To explore the clinical effectiveness interferon combined with low dose HA assisted in the treatment of patients with chronic myelocytic leukemia. Methods 58 cases from March 2002 to February 2011 definitely diagnosed as chronic myelocytic leukemia were selected as the subjects and divided into two group including observation group and control group, each of which had 29 cases. In the control group, the patients received low dose HA treatment as homoharringtonine (HHT) combined with cytosine arabinoside (Ara-c). In the observation group, the patients received regrouped α-2b interferon based on the program of control group. Results The total effective rates of hematological release were 93.10% in observation group and 72.41% in control group with significant difference between two groups (P 0.05). Conclusion Low dose HA treatment combined with regrouped α-2b interferon being worthy of generalization have synergistic effect on chronic myelocytic leukemia and can produce favorable cytogenetic response with evidently decreased leukocyte and high remission rate of hematology. [Key words] Chronic myelocytic leukemia; HHT; Ara-c; Regrouped α-2b interferon

文档评论(0)

docman126 + 关注
实名认证
内容提供者

该用户很懒,什么也没介绍

版权声明书
用户编号:7042123103000003

1亿VIP精品文档

相关文档